banner ad
banner ad

Aesthetic Medicine / MediSpa News

Botox could be the cure for baldness

June 24, 2009 | 0

Botox, the antiwrinkle injection, is being used as a surprise treatment for baldness.  Dr Simon Ourian, a cosmetic surgeon based in Beverly Hills, California, claimed that he stumbled upon its unexpected powers by accident while treating his mother who was suffering from migraines after having chemotherapy which had made her hair fall out.

Read More

Medicis Begins Shipping Dysport for Glabellar Lines

June 19, 2009 | 0

Medicis announced June 15 that it has begun shipment to physicians of DYSPORT (abobotulinumtoxinA) for the treatment of glabellar lines. DYSPORT is an acetylcholine release inhibitor and a neuromuscular blocking agent, approved by the U.S. Food and Drug Administration (FDA) in late April 2009. The approval included two separate indications, the treatment of cervical dystonia […]

Read More

Survey Shows Majority Of Respondents Openly Discuss Use Of BOTOX® Cosmetic And Hyaluronic Acid Dermal Fillers

June 4, 2009 | 0

Despite what some may think, people aren’t hiding their use of BOTOX® Cosmetic and hyaluronic acid dermal fillers. In fact, according to survey statistics released today by The Aesthetic Surgery Education & Research Foundation (ASERF), the research arm of the American Society for Aesthetic Plastic Surgery (ASAPS), nearly nine out of 10 respondents (87 percent) […]

Read More

Tattoos have moved into the cosmetic realm

June 2, 2009 | 0

Once only gracing the skin of rough-and-ready bikies and sailors, today mothers, aunts and grannies are also turning to tattoos. But these women do not sport pin-up girls or skulls and crossbones, instead they are opting for tattooed brows, eyes and lips. Unlike regular body art tattoos, the cosmetic variety uses a subtle colour palette […]

Read More

Don’t let recession pressures up your exposure: under-promise and over-deliver

May 31, 2009 | 0

Just three years ago, cosmetic interventions held a power that catapulted market demand for fillers, lasers and injections of botulinum toxin — a power that established aesthetic medicine as an endless frontier for fee-for-service business. Fast forward to today’s economic recession: It’s clear that even this business is affected, as many consumers are re-evaluating their […]

Read More

Advances being made in engineering of injectable soft tissue filler

May 31, 2009 | 0

Fillers have become a mainstay in cosmetic and rejuvenation treatments in aesthetic medicine today. A recent study demonstrates that a novel tissue-engineered filler, developed using a combination of adipose stem cells (ASC) and micronized acellular dermal matrix (Alloderm), is showing promise for many cosmetic and medical indications. Its developers claim it offers a softer, more […]

Read More

Pigmentary Issues are Common in Aesthetic Medicine

May 25, 2009 | 0

Pigmentary problems including post-inflammatory hyperpigmentation, dyschromia and melasma are among the most common issues in aesthetic medicine, particularly in darker-skinned patients. Yet the threat of a ban from the FDA in 2006 put a cloud over the agent widely considered in the U.S. to be the gold standard for treatment of these skin problems — […]

Read More

Fractional Resurfacing: Should We Believe the Hype?

May 8, 2009 | 0

Fractional resurfacing–a cosmetic treatment that reduces acne scarring, alleviates dark pigmentation, and improves other conditions of the skin–has been regaled as a cutting-edge innovation that promotes more rapid healing, fewer side effects and less downtime than ablative laser skin treatments. But do the results justify the cost of the treatment?

Read More

Acne Therapy: A Clearer Path to Healthier-Looking Skin

May 1, 2009 | 0

What’s new and what’s promising Dermatologists, plastic surgeons or family physicians with added training in aesthetic medicine may offer procedural options in additional to traditional medications for the treatment of acne. These may include one or more of the following: Photodynamic therapy (PDT) in combination with a topical photosensitizer known as 5-aminolevulinic acid (ALA) has […]

Read More

FDA Approves the latest Botulinum Toxin Type A: DYSPORT

May 1, 2009 | 0

Medicis (NYSE:MRX) and Ipsen (Euronext:IPN) announced the U.S. Food and Drug Administration’s (FDA) approval of the Biologics License Application (BLA) for DYSPORT(TM) (abobotulinumtoxinA), an acetylcholine release inhibitor and a neuromuscular blocking agent. The approval includes two separate indications, the treatment of cervical dystonia in adults to reduce the severity of abnormal head position and neck […]

Read More

banner ad
banner ad